Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutation

DLOUHY, Ivan, ARMENGOL, Marc, RECASENS ZORZO, Clara, RIBEIRO, Marcelo l., PÉREZ GALÁN, Patricia, BOSCH, Francesc, LÓPEZ GUILLERMO, Armando, ROUE, Gaël. Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with <i>MYD88</i> L265P mutation. _Haematologica_. 2022. Vol.  107, núm. 12, pàgs. 2990-2990. [consulta: 28 de gener de 2026]. ISSN: 1592-8721. [Disponible a: https://hdl.handle.net/2445/207746]